Bloomberg Law
Sept. 8, 2016, 4:00 AM

Cancer ‘Moonshot’ Scientific Agenda Released

The White House cancer “moonshot” initiative to accelerate new therapies and prevention strategies took a big step forward Sept. 7 with the release of an advisory panel report that lays out the scientific agenda for the effort.

The report includes recommendations for data sharing, patient-focused initiatives and emerging therapies involving the immune system. The National Cancer Advisory Board (NCAB), the presidentially appointed advisory board to the National Cancer Institute (NCI), part of the National Institutes of Health, received the report from its blue ribbon panel at a Sept. 7 meeting.

“As we envision what the moonshot will look like, it will not feel like business as usual.”
Tyler Jacks, co-chairman, NCAB blue ribbon panel